Stillwater Capital Advisors, LLC Merck & Co., Inc. Transaction History

Stillwater Capital Advisors, LLC

$773 Million
Q3 2024

A detailed history of Stillwater Capital Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Stillwater Capital Advisors, LLC holds 180,338 shares of MRK stock, worth $17.7 Million. This represents 2.65% of its overall portfolio holdings.

Number of Shares

180,338

Previous 182,484 1.18%

Holding current value

$17.7 Million

Previous $22.6 Million 9.35%

% of portfolio

2.65%

Previous 3.15%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$111.15 - $128.97 $238,527 - $276,769	-2,146 Reduced 1.18%	180,338 $20.5 Million
Q2 2024 Jul 11, 2024	SELL	$123.8 - $132.96 $317,547 - $341,042	-2,565 Reduced 1.39%	182,484 $22.6 Million
Q1 2024 Apr 16, 2024	SELL	$113.24 - $131.95 $97,952 - $114,136	-865 Reduced 0.47%	185,049 $24.4 Million
Q4 2023 Jan 18, 2024	SELL	$100.18 - $109.02 $84,551 - $92,012	-844 Reduced 0.45%	185,914 $20.3 Million
Q3 2023 Oct 10, 2023	SELL	$102.95 - $114.33 $17,295 - $19,207	-168 Reduced 0.09%	186,758 $19.2 Million
Q2 2023 Jul 12, 2023	SELL	$108.61 - $118.38 $74,289 - $80,971	-684 Reduced 0.36%	186,926 $21.6 Million
Q1 2023 May 01, 2023	SELL	$102.94 - $114.86 $439,142 - $489,992	-4,266 Reduced 2.22%	187,610 $20 Million
Q4 2022 Jan 12, 2023	SELL	$87.44 - $112.11 $384,123 - $492,499	-4,393 Reduced 2.24%	191,876 $0
Q3 2022 Oct 14, 2022	SELL	$84.53 - $94.96 $1.11 Million - $1.24 Million	-13,097 Reduced 6.26%	196,269 $16.9 Million
Q2 2022 Jul 13, 2022	BUY	$83.49 - $94.64 $181,173 - $205,368	2,170 Added 1.05%	209,366 $19.1 Million
Q1 2022 Apr 21, 2022	SELL	$73.51 - $82.4 $388,941 - $435,978	-5,291 Reduced 2.49%	207,196 $17 Million
Q4 2021 Jan 31, 2022	SELL	$72.28 - $90.54 $127,429 - $159,622	-1,763 Reduced 0.82%	212,487 $16.3 Million
Q3 2021 Nov 01, 2021	SELL	$71.68 - $78.83 $78,848 - $86,713	-1,100 Reduced 0.51%	214,250 $16.1 Million
Q2 2021 Jul 22, 2021	SELL	$70.31 - $77.77 $8,507 - $9,410	-121 Reduced 0.06%	215,350 $16.7 Million
Q1 2021 Apr 26, 2021	SELL	$68.86 - $81.11 $5,508 - $6,488	-80 Reduced 0.04%	215,471 $16.6 Million
Q4 2020 Jan 28, 2021	SELL	$71.77 - $79.65 $79,664 - $88,411	-1,110 Reduced 0.51%	215,551 $17.6 Million
Q3 2020 Oct 22, 2020	SELL	$73.18 - $82.95 $83,352 - $94,480	-1,139 Reduced 0.52%	216,661 $18 Million
Q2 2020 Jul 24, 2020	BUY	$70.42 - $80.13 $100,982 - $114,906	1,434 Added 0.66%	217,800 $16.8 Million
Q1 2020 Apr 17, 2020	SELL	$63.36 - $87.82 $43,021 - $59,629	-679 Reduced 0.31%	216,366 $16.6 Million
Q4 2019 Jan 21, 2020	BUY	$77.58 - $87.54 $66,563 - $75,109	858 Added 0.4%	217,045 $19.7 Million
Q3 2019 Oct 11, 2019	SELL	$76.08 - $82.93 $251,748 - $274,415	-3,309 Reduced 1.51%	216,187 $18.2 Million
Q2 2019 Jul 25, 2019	SELL	$69.84 - $81.59 $1.41 Million - $1.64 Million	-20,139 Reduced 8.4%	219,496 $18.4 Million
Q1 2019 Apr 25, 2019	SELL	$69.58 - $79.36 $401,615 - $458,065	-5,772 Reduced 2.35%	239,635 $19.9 Million
Q4 2018 Jan 14, 2019	SELL	$65.24 - $75.71 $206,941 - $240,152	-3,172 Reduced 1.28%	245,407 $18.8 Million
Q3 2018 Oct 23, 2018	SELL	$57.69 - $67.84 $14.2 Million - $16.7 Million	-246,330 Closed	0 $0
Q2 2018 Jul 13, 2018	SELL	$50.83 - $59.72 $156,861 - $184,295	-3,086 Reduced 1.24%	246,330 $15 Million
Q1 2018 Apr 18, 2018	BUY	$50.96 - $59.23 $642,758 - $747,067	12,613 Added 5.33%	249,416 $13.6 Million
Q4 2017 Jan 12, 2018	BUY	$51.62 - $61.64 $1.94 Million - $2.32 Million	37,624 Added 18.89%	236,803 $13.3 Million
Q3 2017 Oct 11, 2017	BUY	$58.67 - $63.13 $11.7 Million - $12.6 Million	199,179	199,179 $12.8 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stillwater Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stillwater Capital Advisors, LLC with notifications on news.

Account

Stillwater Capital Advisors, LLC Merck & Co., Inc. Transaction History